Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Periodontol ; 88(2): 190-196, 2017 02.
Article in English | MEDLINE | ID: mdl-27739344

ABSTRACT

BACKGROUND: Developing a drug carrier with favorable handling characteristics that can respond to environmental changes after inflammation, such as pH changes, may be beneficial for treating periodontitis. This study aims to investigate the preclinical feasibility of using naringin, a naturally derived polymethoxylated flavonoid compound with anti-inflammatory properties, to inhibit periodontitis induction via a thermogelling and pH-responsive injectable hydrogel. METHODS: The hydrogel was made of amphipathic carboxymethyl-hexanoyl chitosan (CHC), ß-glycerol phosphate (ß-GP), and glycerol. Thermogelling and pH-responsive characteristics of the hydrogel, as well as cell viability after treatment with the hydrogel containing naringin, were evaluated in vitro. Hydrogel was subgingivally delivered when experimental periodontitis was induced in vivo, and therapeutic effect was evaluated with microcomputed tomography imaging, histology, and expression of inflammation-associated genes, including toll-like receptor (TLR)2, the receptor for advanced glycation end products (RAGE), myeloid differentiation primary response gene-88, and tumor necrosis factor (TNF)-α. RESULTS: The hydrogel was consistently fluidic at 4°C but rapidly gelled at 37°C. Release of naringin was faster at pH 5.5 to 6.5, and viability was significantly promoted by treatment with 0.85% naringin. Naringin-carrying CHC-ß-GP-glycerol hydrogel sites showed significantly reduced periodontal bone loss (P <0.05) and inflammatory infiltration (P <0.01) as well as significantly downregulated TLR2 (P <0.05), RAGE (P <0.01), and TNF-α (P <0.05) relative to the sites with experimental periodontitis alone. CONCLUSION: Naringin-carrying CHC-ß-GP-glycerol colloidal hydrogel can be used to inhibit induction of experimental periodontitis with favorable handling and inflammation-responsive characteristics.


Subject(s)
Drug Carriers/pharmacology , Flavanones/pharmacology , Hydrogel, Polyethylene Glycol Dimethacrylate/pharmacology , Periodontitis/prevention & control , Animals , Cell Survival , Cells, Cultured , Disease Models, Animal , Drug Carriers/chemistry , Humans , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Male , Mice , Mice, Inbred C57BL , Periodontal Ligament/cytology , Periodontitis/diagnostic imaging , X-Ray Microtomography
2.
Plant Mol Biol ; 93(3): 299-311, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27866313

ABSTRACT

KEY MESSAGE: Sugar regulation of gene expression has profound effects at all stages of the plant life cycle. Although regulation at the transcriptional level is one of the most prominent mechanisms by which gene expression is regulated, only a few transcription factors have been identified and demonstrated to be involved in the regulation of sugar-regulated gene expression. OsMYBS1, an R1/2-type MYB transcription factor, has been demonstrated to be involved in sugar- and hormone-regulated α-amylase gene expression in rice. Arabidopsis contains two OsMYBS1 homologs. In the present study, we investigate MYBS1 and MYBS2 in sugar signaling in Arabidopsis. Our results indicate that MYBS1 and MYBS2 play opposite roles in regulating glucose and ABA signaling in Arabidopsis during seed germination and early seedling development. MYB proteins have been classified into four subfamilies: R2R3-MYB, R1/2-MYB, 3R-MYB, and 4R-MYB. An R1/2-type MYB transcription factor, OsMYBS1, has been demonstrated to be involved in sugar- and hormone-regulated α-amylase genes expression in rice. In this study, two genes homologous to OsMYBS1, MYBS1 and MYBS2, were investigated in Arabidopsis. Subcellular localization analysis showed that MYBS1 and MYBS2 were localized in the nucleus. Rice embryo transient expression assays indicated that both MYBS1 and MYBS2 could recognize the sugar response element, TA-box, in the promoter and induced promoter activity. mybs1 mutant exhibited hypersensitivity to glucose, whereas mybs2 seedlings were hyposensitive to it. MYBS1 and MYBS2 are involved in the control of glucose-responsive gene expression, as the mybs1 mutant displayed increased expression of a hexokinase gene (HXK1), chlorophyll a/b-binding protein gene (CAB1), ADP-glucose pyrophosphorylase gene (APL3), and chalcone synthase gene (CHS), whereas the mybs2 mutant exhibited decreased expression of these genes. mybs1 also showed an enhanced response to abscisic acid (ABA) in the seed germination and seedling growth stages, while mybs2 showed reduced responses. The ABA biosynthesis inhibitor fluridone rescued the mybs1 glucose-hypersensitive phenotype. Moreover, the mRNA levels of three ABA biosynthesis genes, ABA1, NCED9, and AAO3, and three ABA signaling genes, ABI3, ABI4, and ABI5, were increased upon glucose treatment of mybs1 seedlings, but were decreased in mybs2 seedlings. These results indicate that MYBS1 and MYBS2 play opposite roles in regulating glucose and ABA signaling in Arabidopsis during seed germination and early seedling development.


Subject(s)
Arabidopsis Proteins/metabolism , Arabidopsis/metabolism , Carbohydrate Metabolism , Signal Transduction , Transcription Factors/metabolism , Abscisic Acid/pharmacology , Arabidopsis/drug effects , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Carbohydrate Metabolism/drug effects , Carbohydrate Metabolism/genetics , Gene Expression Regulation, Plant/drug effects , Genes, Plant , Genetic Complementation Test , Germination/drug effects , Glucose/pharmacology , Oryza/embryology , Oryza/genetics , Plants, Genetically Modified , Promoter Regions, Genetic , Seeds/drug effects , Seeds/growth & development , Seeds/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Transcription Factors/genetics
3.
J Periodontol ; 87(6): 742-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26891246

ABSTRACT

BACKGROUND: Stimulus-responsive devices have emerged as a novel approach for local drug delivery. This study investigates the feasibility of a novel chitosan-based, pH-responsive hydrogel loaded with N-phenacylthiazolium bromide (PTB), which cleaves the crosslinks of advanced glycation end products on the extracellular matrix. METHODS: A chitosan-based hydrogel loaded with PTB was fabricated, and the in vitro release profile was evaluated within pH 5.5 to 7.4. BALB/cJ mice and Sprague-Dawley rats were used to evaluate the effects during the induction and recovery phases of periodontitis, respectively, and animals in each phase were divided into four groups: 1) no periodontitis induction; 2) ligature-induced experimental periodontitis (group PR); 3) experimental periodontitis plus hydrogel without PTB (group PH); and 4) experimental periodontitis plus hydrogel with PTB (group PP). The therapeutic effects were evaluated by microcomputed tomographic imaging of periodontal bone level (PBL) loss and histomorphometry for inflammatory cell infiltration and collagen density. RESULTS: PTB was released faster at pH 5.5 to 6.5 and consistently slower at pH 7.4. In the induction phase, PBL and inflammatory cell infiltration were significantly reduced in group PP relative to group PR, and the loss of collagen matrix was significantly reduced relative to that observed in group PH. In the recovery phase, PBL and inflammatory cell infiltration were significantly reduced, and significantly greater collagen deposition was noted in group PP relative to groups PR and PH at 4 and 14 days after silk removal. CONCLUSION: Chitosan-based, pH-responsive hydrogels loaded with PTB can retard the initiation of and facilitate the recovery from experimental periodontitis.


Subject(s)
Alveolar Bone Loss , Hydrogel, Polyethylene Glycol Dimethacrylate/therapeutic use , Periodontitis/therapy , Animals , Rats , Rats, Sprague-Dawley , Thiazoles
4.
Article in English | MEDLINE | ID: mdl-26357705

ABSTRACT

The success of bone augmentation is usually dependent on primary wound closure. This review provides a literature-based system to assess the predictability of achieving primary wound closure. Seven pertinent factors that determine the risk for wound exposure were identified: (1) the width of keratinized mucosa, (2) flap thickness, (3) flap tension, (4) vestibular depth, (5) type and (6) size of the bony defect, and (7) materials used. Clinical cases are used to demonstrate evaluation of these factors. This evaluation system may aid clinicians in differentiating cases with various risks of wound exposure and making decisions on flap modifications and the most appropriate surgical designs.


Subject(s)
Alveolar Ridge Augmentation/methods , Gingiva/surgery , Wound Closure Techniques , Dental Materials , Humans , Risk Factors , Surgical Flaps
SELECTION OF CITATIONS
SEARCH DETAIL
...